Characteristics and serology of pregnant women with cytomegalovirus immunoglobulin G seroconversion during pregnancy in Japan

[1] Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Publ Health 2005;5:70.

[2] Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002;15:680e715.

[3] Koyano S, Morioka I, Oka A, Moriuchi H, Asano K, Ito Y, et al. Japanese congenital cytomegalovirus study group. Congenital cytomegalovirus in Japan: more than 2 year follow up of infected newborns. Pediatr Int 2018;60: 57e62.

[4] Hadar E, Dorfman E, Bardin R, Gabbay-Benziv R, Amir J, Pardo J. Symptomatic congenital cytomegalovirus disease following non-primary maternal infec- tion: a retrospective cohort study. BMC Infect Dis 2017;17:31.

[5] Fowler KB, Pass RF. Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity. Pediatrics 2006;118:e286e92.

[6] Mazzitelli M, Micieli M, Votino C, Visconti F, Quaresima P, Strazzulla A, et al. Knowledge of human cytomegalovirus infection and prevention in pregnant women: a baseline, operational survey. Infect Dis Obstet Gynecol 2017;2017: 5495927.

[7] Wizman S, Lamarre V, Coic L, Kakkar F, Le Meur JB, Rousseau C, et al. Awareness of cytomegalovirus and risk factors for susceptibility among pregnant women, in Montreal, Canada. BMC Pregnancy Childbirth 2016;16:54.

[8] Cannon MJ, Hyde TB, Schmid DS. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol 2011;21:240e55.

[9] Prince HE, Lape-Nixon M. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy. Clin Vaccine Immunol 2014;21:1377e84.

[10] Toriyabe K, Morikawa F, Minematsu T, Ikejiri M, Suga S, Ikeda T. Anti-cyto- megalovirus immunoglobulin M titer for congenital infection in first- trimester pregnancy with primary infection: a multicenter prospective cohort study. J Perinatol 2017;37:1272e7.

[11] Ikuta K, Koshizuka T, Kanno R, Inoue N, Kubo T, Koyano S, et al. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity. Microbiol Immunol 2019;63:172e8.

[12] Tsuge M, Hida AI, Minematsu T, Honda N, Oshiro Y, Yokoyama M, et al. Pro- spective cohort study of congenital cytomegalovirus infection during preg- nancy with fetal growth restriction: serologic analysis and placental pathology. J Pediatr 2019;206:42e8. e2.

[13] Fowler KB, Pass RF. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis 1993;168:552e6.

[14] Natali A, Valcavi P, Medici MC, Dieci E, Montali S, Chezzi C. Cytomegalovirus infection in an Italian population: antibody prevalence, virus excretion and maternal transmission. New Microbiol 1997;20:123e33.

[15] Tagawa M, Minematsu T, Masuzaki H, Ishimaru T, Moriuchi H. Seroepide- miological survey of cytomegalovirus infection among pregnant women in Nagasaki, Japan. Pediatr Int 2010;52:459e62.

[16] Taniguchi K, Watanabe N, Sato A, Jwa SC, Suzuki T, Yamanobe Y, et al. Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study. J Clin Virol 2014;59:192e4.

[17] Kaneko M, Sameshima H, Minematsu T, Kusumoto K, Yamauchi A, Ikenoue T. Maternal IgG avidity, IgM and ultrasound abnormalities: combined method to detect congenital cytomegalovirus infection with sequelae. J Perinatol 2013;33:831e5.

[18] Tanimura K, Tairaku S, Morioka I, Ozaki K, Nagamata S, Morizane M, et al. Universal screening with use of immunoglobulin G avidity for congenital cytomegalovirus infection. Clin Infect Dis 2017;65:1652e8.

[19] Tanimura K, Tairaku S, Ebina Y, Morioka I, Nagamata S, Deguchi K, et al. Prediction of congenital cytomegalovirus infection in high-risk pregnant women. Clin Infect Dis 2017;64:159e65.

[20] Shigemi D, Yamaguchi S, Otsuka T, Kamoi S, Takeshita T. Seroprevalence of cytomegalovirus IgG antibodies among pregnant women in Japan from 2009- 2014. Am J Infect Contr 2015;43:1218e21.

[21] Koshizuka T, Toriyabe K, Sato Y, Ikuta K, Ikeda T, Suzutani T. Congenital cytomegalovirus infection via a re-infected mother with original antigenic sin: a case report. Int J Infect Dis 2018;77:87e9.

[22] Ikuta K, Minematsu T, Inoue N, Kubo T, Asano K, Ishibashi K, et al. Cyto- megalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers. J Clin Virol 2013;58:474e8.

[23] Ikuta K, Ishioka K, Sato Y, Imamura T, Asano K, Koyano S, et al. A novel real- time PCR method for determination and quantification of each cytomegalo- virus glycoprotein H subtype in clinical samples. J Clin Microbiol 2012;50: 499e501.